Neuromuscular Genetics tests in Dubai & UAE

Compare available Neuromuscular Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

1,800.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neuromuscular Genetics test prices

Showing 1–15 of 15 matching tests.

Neuromuscular Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5238 ACTA1 Gene Myopathy with Fiber‑Type Disproportion Genetic Test This genetic test analyzes the ACTA1 gene for mutations associated with congenital myopathy with fibre-type disproportion.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACTA1 gene sequence", "Copy Number Variants in ACTA1"] Parameters [] Preparation ["Genetic counselling session required", "No fasting required"] Indications ["Infants and children with hypotonia, motor delay, or muscle weakness", "Adults with undiagnosed myopathy", "Individuals with a family history of neuromuscular disease"] Measurement technique Confirm with laboratory Codes LOINC: 78603-1 ICD-10: G71.2, Z15.89, Z13.89 Clinical summary This genetic test analyzes the ACTA1 gene for mutations associated with congenital myopathy with fibre-type disproportion.
TEST-4140 B3GALNT2 Gene NGS Test for Congenital Muscular Dystrophy with α‑Dystroglycan Hypoglycosylation This test evaluates the B3GALNT2 gene for pathogenic variants associated with congenital muscular dystrophy-dystroglycanopathy.	Peripheral Whole Blood, Extracted DNA, or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the B3GALNT2 gene", "Abnormal glycosylation of α-dystroglycan"] Parameters [] Preparation ["No fasting required"] Indications ["Suspicion of congenital muscular dystrophy-dystroglycanopathy", "Family history of the condition", "Carrier screening", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 62357-4 ICD-10: G71.0 Clinical summary This test evaluates the B3GALNT2 gene for pathogenic variants associated with congenital muscular dystrophy-dystroglycanopathy.
TEST-3955 BIN1 Gene Centronuclear Myopathy Type 2 Genetic Test This genetic test analyzes the BIN1 gene for mutations associated with Centronuclear Myopathy Type 2.	Whole blood (EDTA), FTA card, or extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BIN1 gene", "Presence of mutations causing CNM2"] Parameters [] Preparation ["Mandatory genetic counseling session prior to sample collection", "Written informed consent required"] Indications ["Clinical suspicion of Centronuclear Myopathy Type 2", "Family history of CNM2", "Carrier screening in families with CNM2"] Measurement technique Confirm with laboratory Codes LOINC: 81315-1 ICD-10: G71.2 Clinical summary This genetic test analyzes the BIN1 gene for mutations associated with Centronuclear Myopathy Type 2.
TEST-5296 CHRNE Gene Congenital Myasthenic Syndrome Genetic Test This genetic test identifies mutations in the CHRNE gene, a common cause of congenital myasthenic syndrome (CMS). It helps establish a definitive diagnosis for patients presenting...	Whole blood (EDTA) or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CHRNE gene pathogenic variants", "Congenital Myasthenic Syndrome (CMS) genetic cause"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Suspected congenital myasthenic syndrome", "Family history of CMS", "Need for definitive genetic diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 82318-0 ICD-10: G70.2 Clinical summary This genetic test identifies mutations in the CHRNE gene, a common cause of congenital myasthenic syndrome (CMS). It helps establish a definitive diagnosis for patients presenting with symptoms suggestive of CMS.
TEST-5246 CRYAB Gene (Desmin-Related Myopathy) Genetic Test This genetic test identifies pathogenic variants in the CRYAB gene associated with desmin-related myofibrillar myopathy.	Whole Blood (EDTA), Extracted DNA (≥1 µg at ≥50 ng/µL), or FTA Card Blood Spot	21–28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CRYAB gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation [] Indications ["Suspected desmin-related myofibrillar myopathy", "Family history of myofibrillar myopathy", "Need for genetic confirmation for surveillance and therapy"] Measurement technique Confirm with laboratory Codes LOINC: 82104-7 ICD-10: G71.11 Clinical summary This genetic test identifies pathogenic variants in the CRYAB gene associated with desmin-related myofibrillar myopathy.
TEST-5358 DES Gene Myofibrillar Myopathy (Desmin‑Related) Genetic Test This genetic test identifies mutations and copy number variations within the DES gene, which are causative for desmin-related myofibrillar myopathy.	Whole blood (EDTA tube, 2–5 mL), Extracted DNA (≥1 µg, concentration ≥25 ng/µL), or Dried Blood Spot on FTA Card (≥3 circles)	3–4 weeks from receipt of properly collected sample and completed pedigree	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DES gene sequence variations (mutations)", "DES gene copy number variations (deletions/duplications)"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counselling session"] Indications ["Diagnosis of suspected desmin-related myofibrillar myopathy", "Carrier screening in families with known DES mutations", "Predictive testing for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 101031-5 ICD-10: G71.8, Z15.09, I42.9 Clinical summary This genetic test identifies mutations and copy number variations within the DES gene, which are causative for desmin-related myofibrillar myopathy.
TEST-4714 DNAJB6 Gene Limb-Girdle Muscular Dystrophy, Autosomal Dominant Type 1E (LGMD1E) Genetic Test This test evaluates the DNAJB6 gene for pathogenic variants associated with Autosomal Dominant Limb-Girdle Muscular Dystrophy Type 1E (LGMD1E).	Whole blood (EDTA tube) or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DNAJB6 gene sequence", "Copy Number Variants (CNVs) in DNAJB6"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected diagnosis of LGMD1E based on clinical presentation", "Family history of LGMD1E", "Carrier screening in affected families"] Measurement technique Confirm with laboratory Codes LOINC: 85726-1 ICD-10: G71.0 Clinical summary This test evaluates the DNAJB6 gene for pathogenic variants associated with Autosomal Dominant Limb-Girdle Muscular Dystrophy Type 1E (LGMD1E).
TEST-5390 GNE Gene Nonaka Myopathy Genetic Test This test screens the entire GNE gene coding region for pathogenic variants associated with Nonaka myopathy.	Peripheral whole blood (EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single-nucleotide variants in GNE gene", "Small insertions/deletions in GNE gene", "Exon-level copy number variations in GNE gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without physician instruction"] Indications ["Clinical suspicion of Nonaka myopathy", "Differential diagnosis of distal myopathies", "Carrier screening for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G71.0 Clinical summary This test screens the entire GNE gene coding region for pathogenic variants associated with Nonaka myopathy.
TEST-4711 LMNA Gene Limb‑Girdle Muscular Dystrophy Type 1B (LGMD1B) Genetic Test This genetic test analyzes the LMNA gene to detect mutations associated with Limb-Girdle Muscular Dystrophy Type 1B (LGMD1B). It identifies pathogenic variants responsible for the...	Peripheral whole blood (3 mL EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["LMNA gene sequence", "Pathogenic variants (point mutations, small indels, CNVs)"] Parameters [] Preparation ["Mandatory genetic counselling session", "Documentation of clinical history", "Drawing a pedigree chart of affected family members"] Indications ["Suspected diagnosis of Limb-Girdle Muscular Dystrophy Type 1B", "Family history of LGMD1B", "Need for definitive molecular diagnosis for management and genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 88215-1 ICD-10: G71.0 Clinical summary This genetic test analyzes the LMNA gene to detect mutations associated with Limb-Girdle Muscular Dystrophy Type 1B (LGMD1B). It identifies pathogenic variants responsible for the condition.
TEST-5239 MEGF10 Gene Myopathy, Early-Onset Genetic Test This test performs full gene sequencing of MEGF10 to detect mutations causing early-onset myopathy (EMARDD).	Peripheral whole blood, extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MEGF10 gene sequence", "Copy Number Variants (CNVs) in MEGF10"] Parameters [] Preparation [] Indications ["Suspected MEGF10-related EMARDD", "Congenital myopathy", "Early-onset neuromuscular disorder"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: G71.0 Clinical summary This test performs full gene sequencing of MEGF10 to detect mutations causing early-onset myopathy (EMARDD).
TEST-4002 MYF6 Gene Centronuclear Myopathy Type 3 Genetic Test This test identifies pathogenic variants within the MYF6 gene associated with Centronuclear Myopathy Type 3.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYF6 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected diagnosis of Centronuclear Myopathy Type 3", "Family history of CNM3", "Genetic counseling for neuromuscular disorders"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G71.2 Clinical summary This test identifies pathogenic variants within the MYF6 gene associated with Centronuclear Myopathy Type 3.
TEST-5370 MYH7 Gene Myosin Storage Myopathy Genetic Test This test identifies pathogenic variants in the MYH7 gene associated with myosin storage myopathy.	Whole blood (EDTA) or DNA (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYH7 gene", "Myosin heavy chain 7 gene sequence"] Parameters [] Preparation ["No specific fasting required.", "Inform phlebotomist of any medications."] Indications ["Suspected myosin storage myopathy", "Family history of myosin storage myopathy", "Need for definitive diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 78520-7 ICD-10: G72.89 Clinical summary This test identifies pathogenic variants in the MYH7 gene associated with myosin storage myopathy.
TEST-3989 RYR1 Gene Central Core Disease Genetic Test This test evaluates the RYR1 gene for variants associated with Central Core Disease and malignant hyperthermia susceptibility.	Peripheral whole blood (3–5 mL in EDTA tube) or FTA card spot	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RYR1 gene sequence", "Pathogenic variants", "Copy number variants"] Parameters [] Preparation ["No specific fasting required", "Inform physician of any relevant medical history"] Indications ["Diagnosis of Central Core Disease", "Assessment of Malignant Hyperthermia susceptibility", "Pre-operative anesthetic risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 82319-9 ICD-10: G71.21, Z15.09 Clinical summary This test evaluates the RYR1 gene for variants associated with Central Core Disease and malignant hyperthermia susceptibility.
TEST-5289 SCN4A Gene Myasthenic Syndrome Genetic Test This genetic test evaluates the SCN4A gene for mutations associated with congenital myasthenic syndrome.	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN4A gene sequence", "Exons and splice sites of SCN4A"] Parameters [] Preparation ["No specific fasting required", "Inform lab of current medications"] Indications ["Suspected congenital myasthenic syndrome", "Family history of myasthenic syndrome", "Unexplained muscle weakness or fatigability"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G70.2 Clinical summary This genetic test evaluates the SCN4A gene for mutations associated with congenital myasthenic syndrome.
TEST-3154 Spino‑Bulbar Muscular Atrophy (SBMA) Genetic Test This test evaluates the androgen receptor (AR) gene for CAG repeat expansions, which are characteristic of Spino-Bulbar Muscular Atrophy (Kennedy disease).	Whole Blood (EDTA)	5 Working Days	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG repeat expansion in the AR gene", "Number of CAG repeats"] Parameters [{"name": "CAG Repeat Number", "reference_range": "Normal: Preparation ["No specific fasting required", "Inform phlebotomist of any known bleeding disorders"] Indications ["Suspected Kennedy disease based on clinical presentation", "Family history of Kennedy disease", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 21666-9 ICD-10: G12.21 Clinical summary This test evaluates the androgen receptor (AR) gene for CAG repeat expansions, which are characteristic of Spino-Bulbar Muscular Atrophy (Kennedy disease).

Category overview

Neuromuscular Genetics: overview

Understanding the broader hereditary factors affecting muscle and nerve integrity empowers families to access proactive, specialized care when symptoms are complex or ambiguous. Integrated into our advanced Genetics department, comprehensive Neuromuscular Genetics screening utilizes multi-gene panels to simultaneously evaluate a wide spectrum of hereditary pathways linked to various limb-girdle dystrophies, motor neuron diseases, and myopathies. Utilizing state-of-the-art genomic profiling, this robust screening uncovers elusive genetic drivers, offering the exact clarity required to safely guide specialized multidisciplinary neurological care, proactive respiratory monitoring, and customized early intervention physical therapies. Highly regarded for clinical excellence among diagnostic labs in Dubai and the UAE, DNA Labs ensures absolute patient confidentiality, unparalleled diagnostic accuracy, and remarkably fast turnaround times. Empower your customized medical care journey—book your neuromuscular genetics testing in UAE, arrange a secure clinical sample transfer, or consult our expert neurogenetics professionals today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.